Syndex Bio

Website

Syndex Bio Inc.

12 Investors
Biotechnology
SANTA MONICA, CA

Syndex Bio is a pioneering biotechnology company dedicated to revolutionizing the pace and depth of biological discovery through the application of advanced technologies. Established in 2022 and located in Cambridge, UK, the company focuses on creating innovative tools designed to enhance research capabilities across various fields in biology and medicine.

Products & Team

Syndex AI Platform

Research PlatformSeed

The Syndex AI Platform is a comprehensive solution that merges molecular technologies, advanced instrumentation, and artificial intelligence to facilitate the analysis of biological samples. It designed to streamline the research workflow, allowing for more efficient data processing and deeper insights.

Value Proposition

The platform addresses the challenge of slow and cumbersome biological analysis by enabling faster and more insightful research, ultimately enhancing the understanding, diagnosis, and treatment of diseases.

Pain Points

The primary challenges addressed by Syndex Bio include the inefficiency of traditional research methodologies, the complexity of analyzing biological data, and the need for more rapid and reliable insights to expedite drug discovery and diagnostics.

Integration of molecular analysis techniques with AIAccelerated data processing for timely resultsUser-friendly interface for researchers
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
SANTA MONICA, CA
Primary headquarters

Funding History

Total Raised:
$15.5M
E

Equity Offering

Closed
February 2025
$15.5M
Raised
Progress
100%
Raised
$15.5M
Target
$15.5M
#000206090125000001